AstraZeneca
This US-focused leadership role shapes the clinical and economic value story for the inhaled respiratory portfolio, including Airsupra and Breztri, by designing and delivering evidence programs that inform strategy and enable appropriate access. The position involves leading integrated evidence initiatives, developing real-world data strategies, and building economic models to support payer-ready value propositions. The role requires close collaboration with cross-functional teams to translate evidence into actionable insights for health systems, payers, and policy makers.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role
Epidemiology and Real‑World Evidence Lead
Digital Biology
Real World Evidence Manager
AbbVie
Director, Global Real-World Evidence & Health Outcomes Research Scientist
GSK plc
Director, Respiratory Biologics - Global Real-World Evidence & Health Outcomes
lifelancer
Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology
GSK plc
Director, Global Epidemiology & Real-World Evidence
shionogi